FN2 Earnings Intelligence
Colgate-Palmolive Company financials
Colgate-Palmolive Company (CL) financial statements and key operating metrics from FN2 Research.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 | 12/31/2026 est. | 12/31/2027 est. |
|---|---|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - | - | - |
| - Cash | $832 | $775 | $966 | $1,096 | $1,288 | - | - |
| + Debt | - | - | - | - | - | - | - |
| Enterprise Value | - | - | - | - | - | - | - |
| Revenue | $17,421 | $17,967 | $19,457 | $20,101 | $20,382 | $21,460.7 | $22,162 |
| % Growth | 5.8% | 3.1% | 8.3% | 3.3% | 1.4% | 5.3% | 3.3% |
| Gross Profit | $10,375 | $10,248 | $11,326 | $12,161 | $12,251 | - | - |
| % Margin | 59.6% | 57.0% | 58.2% | 60.5% | 60.1% | - | - |
| EBITDA | $3,888 | $3,438 | $4,551 | $4,873 | $3,936 | - | - |
| % Margin | 22.3% | 19.1% | 23.4% | 24.2% | 19.3% | - | - |
| Net Income | $2,166 | $1,785 | $2,300 | $2,889 | $2,132 | - | - |
| % Margin | 12.4% | 9.9% | 11.8% | 14.4% | 10.5% | - | - |
| Diluted EPS | $2.55 | $2.13 | $2.77 | $3.51 | $2.63 | $3.81 | $4.04 |
| % Growth | -18.8% | -16.5% | 30.0% | 26.7% | -25.1% | 44.8% | 6.2% |
| Operating Cash Flow | $3,325 | $2,556 | $3,745 | $4,107 | $4,198 | - | - |
| CapEx | $567 | $696 | $705 | $561 | $564 | - | - |
| Free Cash Flow | $2,758 | $1,860 | $3,040 | $3,546 | $3,634 | - | - |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 | 12/31/2026 est. | 12/31/2027 est. |
|---|---|---|---|---|---|---|---|
| Revenue | $17,421 | $17,967 | $19,457 | $20,101 | $20,382 | $21,460.7 | $22,162 |
| Gross Profit | $10,375 | $10,248 | $11,326 | $12,161 | $12,251 | - | - |
| EBITDA | $3,888 | $3,438 | $4,551 | $4,873 | $3,936 | - | - |
| Net Income | $2,166 | $1,785 | $2,300 | $2,889 | $2,132 | - | - |
| Diluted EPS | $2.55 | $2.13 | $2.77 | $3.51 | $2.63 | $3.81 | $4.04 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $832 | $775 | $966 | $1,096 | $1,288 |
| Short-term Debt | - | - | - | - | - |
| Long-term Debt | $7,194 | $8,741 | $8,219 | $7,289 | $6,871 |
| Total Debt | - | - | - | - | - |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $3,325 | $2,556 | $3,745 | $4,107 | $4,198 |
| Capital Expenditure | $567 | $696 | $705 | $561 | $564 |
| Free Cash Flow | $2,758 | $1,860 | $3,040 | $3,546 | $3,634 |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Revenue Growth | 5.8% | 3.1% | 8.3% | 3.3% | 1.4% |
| Gross Margin | 59.6% | 57.0% | 58.2% | 60.5% | 60.1% |
| EBITDA Margin | 22.3% | 19.1% | 23.4% | 24.2% | 19.3% |
| Net Margin | 12.4% | 9.9% | 11.8% | 14.4% | 10.5% |
| FCF Margin | 15.8% | 10.4% | 15.6% | 17.6% | 17.8% |
| Diluted EPS Growth | -18.8% | -16.5% | 30.0% | 26.7% | -25.1% |